Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging (Q36670162)

15 August 2017

Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging (English)

1 reference

mild cognitive impairment

15 August 2017

1 reference

Antonio Di Carlo

10

0 references

Marzia Baldereschi

Marzia Baldereschi

8

0 references

Patrick G. Kehoe

Patrick G Kehoe

6

0 references

Francesco Panza

Francesco Panza

16

0 references

Giancarlo Logroscino

5

Giancarlo Logroscino

1 reference

15 August 2017

Bruno P Imbimbo

7

1 reference

ORCID Public Data File 2021

Vincenzo Solfrizzi

1

Vincenzo Solfrizzi

1 reference

15 August 2017

3

Vincenza Frisardi

1 reference

15 August 2017

4

Davide Seripa

1 reference

15 August 2017

9

Gaetano Crepaldi

1 reference

15 August 2017

11

Lucia Galluzzo

1 reference

15 August 2017

13

Domenico Inzitari

1 reference

Italian Longitudinal Study on Aging Working Group

15 August 2017

17

Italian Longitudinal Study on Aging Working Group

1 reference

15 August 2017

14

Stefania Maggi

1 reference

15 August 2017

Emanuele Scafato

2

1 reference

15 August 2017

Claudia Gandin

12

1 reference

15 August 2017

Alberto Pilotto

15

1 reference

15 August 2017

28 December 2011

1 reference

15 August 2017

1 reference

15 August 2017

35

1 reference

15 August 2017

2

1 reference

15 August 2017

441-453

1 reference

Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Antihypertensive treatments, cognitive decline, and dementia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Angiotensins in Alzheimer's disease - friend or foe?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Hypertension, dementia, and antihypertensive treatment: implications for the very elderly.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Effects of cardiovascular medications on rate of functional decline in Alzheimer disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

The effects of blood pressure reduction on cognitive function: a review of effects based on pooled data from clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

The age-dependent relation of blood pressure to cognitive function and dementia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

The role of inflammation in Alzheimer's disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Mild cognitive impairment: clinical characterization and outcome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

A Measure of Primary Sociobiological Functions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Angiotensin-Converting Enzyme Inhibitors

28 June 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Cross-sectional and longitudinal association between antihypertensive medications and cognitive impairment in an elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Adverse effects profile of sulfhydryl compounds in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Use of computerized neuropsychological tests (CANTAB) to assess cognitive effects of antihypertensive drugs in the elderly. Cambridge Neuropsychological Test Automated Battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Vascular risk factors, incidence of MCI, and rates of progression to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the Italian longitudinal study on aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11357-011-9360-Z

Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer disease.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3592955

Are all angiotensin-converting enzyme inhibitors interchangeable?

20 September 2018

1 reference

12 December 2020

Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs

1 reference

12 December 2020

An Adequate Threshold for Body Mass Index to Detect Underweight Condition in Elderly Persons: The Italian Longitudinal Study on Aging (ILSA)

1 reference

12 December 2020

The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Blockade of angiotensin converting enzyme in circumventricular organs of the brain after oral lisinopril administration demonstrated by quantitative in vitro autoradiography

1 reference

12 December 2020

Assessment of older people: self-maintaining and instrumental activities of daily living

1 reference

12 December 2020

Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288

1 reference

12 December 2020

10.1007/S11357-011-9360-Z

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

22203459

1 reference